Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Germany's Novaliq Sets Up U.S. Subsidiary in Cambridge, Massachusetts

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

As an emerging leader in the field of ophthalmology, Novaliq is currently pursuing two late-stage clinical trials in the United States. Source: BioSpace

Continue ReadingGermany's Novaliq Sets Up U.S. Subsidiary in Cambridge, Massachusetts

What You Need to Know About Cirius Therapeutics

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

With headquarters located in San Diego, Calif. and Kalamazoo, Mich., Cirius Therapeutics is a clinical-stage pharmaceutical company focused on developing a treatment for NASH. Source: BioSpace

Continue ReadingWhat You Need to Know About Cirius Therapeutics

Pfizer Backs and Inks $162M+ Deal With Tiny Adapsyn Bioscience

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

Adapsyn Bioscience today announced that it has completed a round of financing that was co-funded by Pfizer R&D Innovate and Genesys Capital. Source: BioSpace

Continue ReadingPfizer Backs and Inks $162M+ Deal With Tiny Adapsyn Bioscience

5 Top Biotech Stocks That Look Vulnerable in 2018

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

Although the stock market seems to be moving up at the beginning of this year, the U.S. equities market appears more mixed, with healthcare stocks in particular appearing more volatile.…

Continue Reading5 Top Biotech Stocks That Look Vulnerable in 2018

FDA Calls Bay Area Global Blood Therapeutics' Sickle Cell Drug a Breakthrough

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

The BTD decision for voxelotor was based on clinical data submitted from a trio of studies. Source: BioSpace

Continue ReadingFDA Calls Bay Area Global Blood Therapeutics' Sickle Cell Drug a Breakthrough

REGENXBIO Banks on Strong Gene Therapy Pipeline and Potential Partnerships

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

Gene therapy treatment is a high risk, high reward venture, but the promises of a therapy developed through these programs could be life-changing for patients. Source: BioSpace

Continue ReadingREGENXBIO Banks on Strong Gene Therapy Pipeline and Potential Partnerships

Jobs Lost as Cellectar Biosciences Shutters Manufacturing Operations

  • Post author:Sam
  • Post published:January 8, 2018
  • Post category:BioPharma

Cellectar Biosciences is closing its manufacturing operations and contracting them out. Source: BioSpace

Continue ReadingJobs Lost as Cellectar Biosciences Shutters Manufacturing Operations

New Jersey's Leading Pharma, LLC Scores $40M

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

The transaction was led by Signet Healthcare Partners in addition to Crestline Investors with other investors comprised of Cane Investment Partners and existing Leading Pharma members. Source: BioSpace

Continue ReadingNew Jersey's Leading Pharma, LLC Scores $40M

What You Need to Know About Freenome

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

Freenome, headquartered in South San Francisco, is focused on developing a diagnostic test for early detection of cancer and other diseases on the so-called "liquid biopsy," in other words, blood.…

Continue ReadingWhat You Need to Know About Freenome

Teva, Alder BioPharma Forge $200M Anti-CGRP-Based Therapy Pact

  • Post author:Sam
  • Post published:January 7, 2018
  • Post category:BioPharma

The agreement validates Teva’s IP and resolves Alder’s opposition to Teva’s European Patent No. 1957106 B1. Source: BioSpace

Continue ReadingTeva, Alder BioPharma Forge $200M Anti-CGRP-Based Therapy Pact
  • Go to the previous page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 288
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.